Table 5.
Chemokine and cytokine concentration in broncho-alveolar lavage fluid in the mild airway inflammation model.
| Penh | RL | |||||||
|---|---|---|---|---|---|---|---|---|
| SAL-SAL | SAL-OVA | OVA-SAL | OVA-OVA | SAL-SAL | SAL-OVA | OVA-SAL | OVA-OVA | |
| IL-10 | n.d. | n.d. | 17.8 ± 10.6 | n.d. | n.d. | 13.13 ± 6.53 | n.d. | n.d. |
| IL-12p40 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. |
| IL-1b | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. |
| IL-2 | 0.67 ± 0.26 | 1.21 ± 0.08 | n.d. | n.d. | 1.55 ± 0.20 | 1.45 ± 0.28 | 0.91 ± 0.27 | 2.46 ± 0.91 |
| IL-4 | n.d. | n.d. | n.d. | 130.30 ± 75.96 | n.d. | n.d. | 7.06 ± 3.62 | 48.98 ± 12.80 |
| IL-5 | n.d. | n.d. | n.d. | 133.50 ± 53.23 | n.d. | n.d. | 35.85 ± 21.21 | 107.60 ± 71.93 |
| IL-6 | 6.13 ± 4.91 | n.d. | n.d. | 3.90 ± 2.68 | n.d. | n.d. | n.d. | n.d. |
| IL-9 | 49.04 ± 32.71 | 94.25 ± 61.92 | n.d. | n.d. | n.d. | n.d. | 41.45 ± 22.24 | n.d. |
| IP-10 | n.d. | n.d. | n.d. | 5.92 ± 0.05 | n.d. | n.d. | n.d. | 74.58 ± 16.05 |
| KC | 37.92 ± 9.03 | 22.16 ± 4.85 | 29.06 ± 7.80 | 143.90 ± 40.57 | 35.43 ± 3.81 | 61.52 ± 9.12 | 74.17 ± 13.99 | 267.9 ± 92.75 |
| MCP-1 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 35.51 ± 16.98 |
| MIG | n.d. | 5.35 ± 1.71 | n.d. | 3.80 ± 1.59 | n.d. | 5.40 ± 1.80 | 2.02 ± 0.61 | 118.90 ± 41.71 |
| MIP-1α | n.d. | n.d. | n.d. | 83.37 ± 52.98 | n.d. | n.d. | n.d. | 132.80 ± 3.26 |
| MIP-2 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. |
| RANTES | 1.06 ± 0.25 | 1.38 ± 0.39 | 1.03 ± 0.23 | 1.78 ± 0.52 | 2.11 ± 0.50 | 2.18 ± 0.22 | 1.67 ± 0.34 | 1.99 ± 0.60 |
| TNFα | 1.57 ± 0.33 | 2.06 ± 0.42 | 1.98 ± 0.03 | 1.65 ± 0.19 | 1.72 ± 0.23 | 2.21 ± 0.25 | 1.69 ± 0.10 | 1.66 ± 0.29 |